Juan A. Vara-Fresno

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy.

Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy.

Journal: Cancer immunology, immunotherapy : CII

Published: February 02, 2026

Metformin enhances response to chemotherapy combined with immunotherapy in a triple negative breast cancer in vivo model.

Metformin enhances response to chemotherapy combined with immunotherapy in a triple negative breast cancer in vivo model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 16, 2025

Identification of a Muscle-Invasive Bladder Carcinoma Molecular Subtype of Poor Responders to Neoadjuvant Chemotherapy and High Expression of Targetable Biomarkers.

Identification of a Muscle-Invasive Bladder Carcinoma Molecular Subtype of Poor Responders to Neoadjuvant Chemotherapy and High Expression of Targetable Biomarkers.

Journal: International journal of molecular sciences

Published: November 18, 2025

A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.

A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.

Journal: British journal of cancer

Published: November 04, 2024

Layer Analysis Based on RNA-Seq Reveals Molecular Complexity of Gastric Cancer.

Layer Analysis Based on RNA-Seq Reveals Molecular Complexity of Gastric Cancer.

Journal: International journal of molecular sciences

Published: September 11, 2024

Functional proteomics of colon cancer Consensus Molecular Subtypes.

Functional proteomics of colon cancer Consensus Molecular Subtypes.

Journal: British journal of cancer

Published: October 27, 2023

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.

Journal: Cancers

Published: July 25, 2023

Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.

Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.

Journal: Cancer

Published: January 17, 2023

Proteomics Characterization of Clear Cell Renal Cell Carcinoma.

Proteomics Characterization of Clear Cell Renal Cell Carcinoma.

Journal: Journal of clinical medicine

Published: December 01, 2022

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.

Journal: International journal of molecular sciences

Published: November 07, 2022

Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage.

Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage.

Journal: Frontiers in cellular neuroscience

Published: September 30, 2022

Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics.

Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics.

Journal: Cancers

Published: April 20, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026